Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Lifted Spirits teases expansion, recipe for its quirky cocktail of success: Math plus intuition
After noticing more than a decade ago how distillation and cocktails enhanced his own friendship groups, Michael Stuckey set out to create that same sense of community for others. “I fell in love with the idea of spirits first; this idea that spirits were inherently about bringing people together,” said Stuckey, founder of Lifted Spirits…
Black Pantry expands nationally through online shop; founder works to set new standard for buying Black
Kansas City’s premier boutique for Black-owned essentials always had its sights set on building a national identity, said Brian Roberts, but he needed to prove himself and his business on the local level first. “A lot of people were pushing me in the beginning to go the website direction, but I didn’t want to do…
Federal funds will power Missouri investments for the next 8 years; here’s how your startup can apply
Applications are now open for a popular state-run co-investment program that can provide up to a $2 million equity-based investment in Missouri-based companies that have identified a lead investor for the round. The revived Venture Capital Program and specifically IDEA Fund Co-Investment Programs — coordinated by the Missouri Technology Corporation (MTC) — will be largely funded…
LaunchKC finalists: Meet 13 tech startups vying for six $50K grants in rebooted competition
A revived LaunchKC grants competition is set to return in mid-November with more than a dozen companies vying for $300,000 in non-dilutive funding. Finalists were announced Friday. The 13 Kansas City companies selected to compete Nov. 15 were narrowed from more than 90 applicants, said Becca Castro, strategic initiatives manager at the Economic Development Corporation…